Amsterdam, the Netherlands – Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing recall of certain sleep ...

Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG; AEX: PHIA) subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential ...

Philips Respironics has updated use instructions for three bi-level positive airway pressure machines, according to a recall statement posted by the US FDA. The recall does not include removal of the ...

In June of 2021, Philips Respironics issued a recall for some of its CPAP and BiPAP machines. Now the U.S. Food and Drug Administration says the notification to users about the recall “have been ...

One of the nation's largest makers of machines for sleep apnea sufferers has agreed to pay at least $479 million to compensate customers who bought the devices. Philips Respironics and Koninklijke ...

MARKHAM, ON, Canada--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced the Canadian launch of the Philips Respironics V680 Ventilator for hospital respiratory care, offering both ...

The US Food and Drug Administration issued a Class I recall Friday, the most serious type of recall, for certain Philips Respironics DreamStation1 CPAP machines. A Class I recall means the FDA has ...

Philips Respironics has recalled some face masks used with CPAP and BiPap machines because they have magnetic headgear clips that can interfere with other medical devices. The recalled masks are the ...

BiPAP A40 is a new multi-modality bi-level ventilator featuring the first fully automatic ventilation mode, designed to support the smooth transition of treatment from hospital to home Philips ...

(News release) - The U.S. Food and Drug Administration (FDA) is alerting people who use Philips Respironics ventilators, BiPAP, and CPAP machines and their health care providers that Philips ...